SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026)
SS Innovations International (SSII) reported Depreciation & Amortization (CF) of $323747.0 for Q1 2026, up 54.99% on a YoY basis from $208882.0 in Q1 2025, and up 4.61% sequentially from $309491.0 in Q4 2025.
SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
SS Innovations International (SSII) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $323747.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 54.99% year-over-year to $323747.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 110.84% YoY), and the FY2025 full-year result was $1.1 million, up 146.76% from the prior year.
- Depreciation & Amortization (CF) improved to $323747.0 in Q1 2026, from $309491.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $323747.0 in Q1 2026 to a low of $2305.0 in Q1 2022.
- A 5-year average of $121385.2 and a median of $80101.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) slumped 68.59% in 2022 and jumped 1313.93% in 2023, its largest moves.
- Tracing SSII's Depreciation & Amortization (CF) over 5 years: stood at $24832.0 in 2022, then jumped by 89.42% to $47037.0 in 2023, then jumped by 210.24% to $145926.0 in 2024, then jumped by 112.09% to $309491.0 in 2025, then climbed by 4.61% to $323747.0 in 2026.
- Business Quant data shows SSII's Depreciation & Amortization (CF) at $323747.0 in Q1 2026, $309491.0 in Q4 2025, and $297173.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 323,747.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 323,747.00 |
| Mar 31, 2026 | 323,747.00 |
| Dec 31, 2025 | 309,491.00 |
| Dec 31, 2025 | 309,491.00 |
| Sep 30, 2025 | 297,173.00 |
| Sep 30, 2025 | 297,173.00 |
| Jun 30, 2025 | 260,361.00 |
| Jun 30, 2025 | 260,361.00 |
| Mar 31, 2025 | 208,882.00 |
| Mar 31, 2025 | 208,882.00 |
| Dec 31, 2024 | 145,926.00 |
| Dec 31, 2024 | 145,926.00 |
| Sep 30, 2024 | 119,502.00 |
| Sep 30, 2024 | 119,502.00 |
| Jun 30, 2024 | 90,476.00 |
| Jun 30, 2024 | 90,476.00 |
| Mar 31, 2024 | 80,101.00 |
| Mar 31, 2024 | 80,101.00 |
| Dec 31, 2023 | 47,037.00 |
| Dec 31, 2023 | 47,037.00 |